Medical University of Silesia
sum.edu.plTotal trials
107
Active
22
Phase 3
6
Total enrollment
51,280
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Group B | — | — | — | — | — | 1 | |
| Group O | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| omalizumab | — | — | — | — | — | 1 | |
| NOAC | — | — | — | — | — | 1 | |
| Postoperative pain management with acetaminophen | — | — | — | — | — | 1 | |
| Postoperative pain management with dexketoprofen | — | — | — | — | — | 1 | |
| Postoperative pain management with metamizole | — | — | — | — | — | 1 | |
| Preemptive Analgesics | — | — | — | — | — | 1 | |
| Administration of a single or repeated dose of a long half-life antibiotic - oritavancin | — | — | — | — | — | 1 | |
| Administration of a repeated dose of a short half-life antibiotic - vancomycin | — | — | — | — | — | 1 | |
| Subgingival application of 1.2% lovastatin | — | — | — | — | — | 1 | |
| Subgingival application of placebo gel | — | — | — | — | — | 1 | |
| Clobetasol propionate 0.05 percent topical application | — | — | — | — | — | 1 |
Next readouts
- 2025-06-01
- 2026-06-28
- 2026-07
- 2026-10
- 2026-10-01
- 2026-12
- 2027-05
- 2027-10-31
Top conditions
- Temporomandibular Disorder5
- Predictive Value of Tests4
- Vitreoretinal Surgeries3
- Postoperative Nausea and Vomiting3
- Postoperative Pain3
- Myofascial Pain3
- Coronary Artery Calcification3
- Coronary Artery Disease3
Frequently asked questions about Medical University of Silesia
- How many clinical trials does Medical University of Silesia have on ClinicalTrials.gov?
- Medical University of Silesia is listed as the lead sponsor on 107 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of Silesia's trials are in Phase 3?
- 6 of Medical University of Silesia's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Medical University of Silesia focus on?
- Medical University of Silesia's most-studied conditions on ClinicalTrials.gov are Temporomandibular Disorder, Predictive Value of Tests, Vitreoretinal Surgeries, Postoperative Nausea and Vomiting, Postoperative Pain.
- When are Medical University of Silesia's next clinical trial readouts?
- Medical University of Silesia has 8 upcoming primary-completion readouts tracked here; the soonest is “The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab”, expected around 2025-06-01.